Click to enlarge

selenase® 50 AP

Indication

Proven selenium deficiency that cannot be corrected nutritionally. Selenium deficiency may occur in maldigestion and malabsorption states, as well as in malnutrition and nutritional deficiency.

PZN Package Size
04445609

04445615

04445621

 20 Tablets (N1) (50 µg Selenium)

50 Tablets (N2) (50 µg Selenium)

100 Tablets (N3) (50 μg Selenium)
Category:
Description

Product Group

Trace elements, available only in pharmacies.

Active Ingredient

Sodium selenite pentahydrate.
50 µg selenium per tablet.

Composition

Tablet contains 0.167 mg sodium selenite pentahydrate (equivalent to 50 µg selenium).

Other Ingredients

Magnesium stearate (Ph. Eur.), corn starch, povidone K 25, sucrose, talcum.

Contraindications

Hypersensitivity to sodium selenite pentahydrate or any of the other ingredients. Selenium intoxications.

Side effects

Not known so far when used as directed.

Dosage form

20 (N1), 50 (N2), 100 (N3) Tablets.

Fachinformationen

Gebrauchsinformationen

Package Size: 20 Tablets (N1) (50 µg Selenium)

PNZ : 04445609

Package Size: 50 Tablets (N1) (50 µg Selenium)

PNZ : 04445615